We don't follow Denmark's vaccine recommendations because we don't live in Denmark.
In a move that formalizes months of quiet bureaucratic realignment, President Trump signed an executive order directing the CDC to reduce its recommended childhood vaccine schedule from 17 to 11 immunizations, citing comparisons with peer nations as justification. The decision, shaped in part by a newly appointed advisory panel selected by Health Secretary Robert F. Kennedy Jr., represents a deliberate departure from the scientific consensus-building process that has long governed American public health policy. The medical establishment has responded with rare institutional defiance — the American Academy of Pediatrics issued its own competing guidance, and a federal court has already found the panel appointments unlawful. At stake is a foundational question that societies have wrestled with across generations: who holds the authority to define the boundaries of protection we owe to our children.
- A presidential executive order has formalized the reduction of CDC-recommended childhood vaccines from 17 to 11, codifying changes already quietly set in motion since January.
- The wholesale replacement of all 17 members of the CDC's vaccine advisory panel with appointees skeptical of mainstream vaccine science has alarmed public health professionals and legal observers alike.
- A federal judge ruled in March that the new panel's appointments violated federal law and that the administration bypassed the established, evidence-based process for setting vaccine policy.
- The American Academy of Pediatrics broke with federal guidance and issued its own recommendations, arguing that U.S. disease risks and health infrastructure cannot be fairly compared to European nations.
- Vaccines for RSV, hepatitis A and B, dengue, and meningococcal disease are now restricted to high-risk children only, leaving the broader population without previously standard protections.
- Whether further reductions are coming — and what the downstream public health consequences will be — remains an open and urgent question as the administration signals it intends to keep reshaping vaccine policy.
President Trump signed an executive order on Friday directing the CDC to reduce its recommended childhood vaccine schedule from 17 to 11 immunizations, formalizing a shift that had already been unfolding within the federal health bureaucracy since the start of the year.
The chain of decisions began in December, when Trump asked the Department of Health and Human Services to align American vaccine recommendations with those of other developed nations. HHS released an assessment in January concluding that the United States recommends more childhood vaccines than any comparable country — in some cases more than twice the doses administered in Europe. The CDC then announced it would scale back its recommendations accordingly.
Under the new framework, vaccines for RSV, hepatitis A and B, dengue, and meningococcal disease are now reserved for high-risk children only. The CDC retained recommendations for 11 core immunizations, including measles, polio, whooping cough, and HPV. The White House described the order as an affirmation of "gold-standard science" and a way to give doctors and families greater flexibility.
The medical community has pushed back forcefully. The American Academy of Pediatrics issued its own competing vaccine guidance, and in March a federal judge ruled that the administration had violated federal law in appointing the new advisory panel that shaped these changes — finding also that the traditional, science-grounded process for developing vaccine policy had been bypassed.
That panel was assembled by Health Secretary Robert F. Kennedy Jr., who has long questioned mainstream vaccine science. All 17 members of the previous panel were replaced, and several new appointees have publicly disputed established medical research. The Academy of Pediatrics argues that international comparisons are misleading — American children face different disease threats and operate within a different health system than their European counterparts, as one of the Academy's infectious disease specialists made plain.
The executive order directs the CDC and its advisory committee to review the HHS assessment and latest clinical data before taking further steps. Whether additional reductions are coming, and what the public health consequences will ultimately be, remains to be seen.
On Friday, President Trump signed an executive order instructing the CDC to reduce the number of recommended childhood vaccines from 17 to 11, formalizing a shift that had already begun earlier in the year within the federal health bureaucracy.
The directive follows a chain of decisions that started in December, when Trump issued a memo asking the Department of Health and Human Services to align American vaccine recommendations with those of other developed nations. In January, HHS released an assessment concluding that the United States recommends more childhood vaccines than any comparable country—in some cases, more than twice as many doses as European nations administer. The CDC, which operates under HHS, then announced in January that it would pare back its recommendations accordingly.
Under the new framework, only children in high-risk categories will receive vaccines for respiratory syncytial virus, hepatitis A, hepatitis B, dengue, and meningococcal disease. The CDC maintained recommendations for 11 core immunizations: measles, mumps, rubella, whooping cough, tetanus, diphtheria, Haemophilus influenzae type b, pneumonia, polio, human papillomavirus, and chickenpox. The White House framed the order as an affirmation of "gold-standard science" and an effort to give doctors and families greater flexibility in medical decision-making.
The changes have provoked significant resistance from the medical establishment. The American Academy of Pediatrics broke with CDC guidance and released its own childhood vaccine recommendations. In March, a federal judge sided with the Academy and other plaintiffs in a lawsuit, ruling that the government had violated federal law in appointing the new advisory panel that shaped these recommendations. The judge also found that the administration had disregarded the traditional, scientifically grounded process for developing vaccine policy.
The new advisory panel was selected by Health Secretary Robert F. Kennedy Jr., who has long questioned mainstream vaccine science. All 17 members of the previous panel were replaced, and several of the new appointees have publicly disputed established medical research on vaccines. This wholesale turnover marked a sharp departure from how such panels have historically been constituted.
The administration's core argument rests on international comparison: American children receive more vaccines than their counterparts in peer nations. But the Academy of Pediatrics counters that most developed countries follow broadly similar practices, and any differences reflect country-specific disease risks and health system structures. Dr. Jose Romero, a member of the Academy's infectious disease committee, put it plainly: the United States does not follow Denmark's vaccine schedule because American children face different disease threats and operate within a different health infrastructure.
The executive order directs the CDC and its advisory committee to review the HHS assessment and latest clinical data, then take "appropriate steps" to update the childhood vaccine schedule. What that means in practice—whether further reductions are coming, how quickly changes will be implemented, and what the public health consequences might be—remains to be seen. The order essentially codifies decisions already in motion, but it also signals that the administration intends to continue reshaping vaccine policy according to its own framework.
Citas Notables
We don't follow Denmark's vaccine recommendations because we don't live in Denmark. Children in the United States are at risk of different diseases than children in other countries.— Dr. Jose Romero, American Academy of Pediatrics
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter how many vaccines we recommend compared to Denmark or Germany?
Because the argument assumes that fewer vaccines is inherently better—that we're over-vaccinating. But the real question is whether American children face different disease risks. They do. We have different disease prevalence, different population densities, different travel patterns.
So the comparison itself is flawed?
It's misleading. You can't just count doses and say one country is doing it right. You have to ask: what diseases are circulating here? What's the epidemiology? The Academy of Pediatrics is saying we've built our schedule based on American disease patterns, not European ones.
What about the court ruling? That seems significant.
It is. A federal judge found that the process itself was broken—that the government replaced an entire advisory panel and disregarded the traditional scientific method for making these decisions. That's not about whether the final number is 11 or 17. It's about whether the decision was made properly.
And Kennedy's role in this—what's the concern there?
He's a vaccine skeptic. He selected every member of the new panel. Several of them have publicly questioned established vaccine science. So there's a credibility problem from the start. The medical community sees this as ideology driving policy, not evidence.
What happens to families now?
That's the uncertainty. Doctors and parents have more discretion, which sounds good in theory. But if fewer children get vaccinated for diseases like RSV or hepatitis B, you could see outbreaks in vulnerable populations. We won't know the real impact for months or years.